177 related articles for article (PubMed ID: 29449607)
1. 6-Thioguanine is a noncompetitive and slow binding inhibitor of human deubiquitinating protease USP2.
Chuang SJ; Cheng SC; Tang HC; Sun CY; Chou CY
Sci Rep; 2018 Feb; 8(1):3102. PubMed ID: 29449607
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of ubiquitin recognition by the deubiquitinating protease USP2.
Renatus M; Parrado SG; D'Arcy A; Eidhoff U; Gerhartz B; Hassiepen U; Pierrat B; Riedl R; Vinzenz D; Worpenberg S; Kroemer M
Structure; 2006 Aug; 14(8):1293-302. PubMed ID: 16905103
[TBL] [Abstract][Full Text] [Related]
3. Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models.
Davis MI; Pragani R; Fox JT; Shen M; Parmar K; Gaudiano EF; Liu L; Tanega C; McGee L; Hall MD; McKnight C; Shinn P; Nelson H; Chattopadhyay D; D'Andrea AD; Auld DS; DeLucas LJ; Li Z; Boxer MB; Simeonov A
J Biol Chem; 2016 Nov; 291(47):24628-24640. PubMed ID: 27681596
[TBL] [Abstract][Full Text] [Related]
4. Yeast Two-Hybrid Analysis for Ubiquitin Variant Inhibitors of Human Deubiquitinases.
Pascoe N; Seetharaman A; Teyra J; Manczyk N; Satori MA; Tjandra D; Makhnevych T; Schwerdtfeger C; Brasher BB; Moffat J; Costanzo M; Boone C; Sicheri F; Sidhu SS
J Mol Biol; 2019 Mar; 431(6):1160-1171. PubMed ID: 30763569
[TBL] [Abstract][Full Text] [Related]
5. Deubiquitinating enzymes in skeletal muscle atrophy-An essential role for USP19.
Wing SS
Int J Biochem Cell Biol; 2016 Oct; 79():462-468. PubMed ID: 27475983
[TBL] [Abstract][Full Text] [Related]
6. Disulfiram and 6-Thioguanine synergistically inhibit the enzymatic activities of USP2 and USP21.
Lin HC; Kuan Y; Chu HF; Cheng SC; Pan HC; Chen WY; Sun CY; Lin TH
Int J Biol Macromol; 2021 Apr; 176():490-497. PubMed ID: 33582217
[TBL] [Abstract][Full Text] [Related]
7. Ribonucleotide reductase holoenzyme inhibitor COH29 interacts with deubiquitinase ubiquitin-specific protease 2 and downregulates its substrate protein cyclin D1.
Zhu M; Wang H; Ding Y; Yang Y; Xu Z; Shi L; Zhang N
FASEB J; 2022 May; 36(5):e22329. PubMed ID: 35476303
[TBL] [Abstract][Full Text] [Related]
8. Validation of catalytic site residues of Ubiquitin Specific Protease 2 (USP2) by molecular dynamic simulation and novel kinetics assay for rational drug design.
Ullah S; Junaid M; Liu Y; Chen S; Zhao Y; Wadood A
Mol Divers; 2023 Jun; 27(3):1323-1332. PubMed ID: 35932436
[TBL] [Abstract][Full Text] [Related]
9. Development of a highly reliable assay for ubiquitin-specific protease 2 inhibitors.
Wang Z; Xie W; Zhu M; Zhou H
Bioorg Med Chem Lett; 2017 Sep; 27(17):4015-4018. PubMed ID: 28778469
[TBL] [Abstract][Full Text] [Related]
10. The Deubiquitylase USP2 Regulates the LDLR Pathway by Counteracting the E3-Ubiquitin Ligase IDOL.
Nelson JK; Sorrentino V; Avagliano Trezza R; Heride C; Urbe S; Distel B; Zelcer N
Circ Res; 2016 Feb; 118(3):410-9. PubMed ID: 26666640
[TBL] [Abstract][Full Text] [Related]
11. Increased acid ceramidase expression depends on upregulation of androgen-dependent deubiquitinases, USP2, in a human prostate cancer cell line, LNCaP.
Mizutani N; Inoue M; Omori Y; Ito H; Tamiya-Koizumi K; Takagi A; Kojima T; Nakamura M; Iwaki S; Nakatochi M; Suzuki M; Nozawa Y; Murate T
J Biochem; 2015 Oct; 158(4):309-19. PubMed ID: 25888580
[TBL] [Abstract][Full Text] [Related]
12. Deubiquitylating enzyme USP2 counteracts Nedd4-2-mediated downregulation of KCNQ1 potassium channels.
Krzystanek K; Rasmussen HB; Grunnet M; Staub O; Olesen SP; Abriel H; Jespersen T
Heart Rhythm; 2012 Mar; 9(3):440-8. PubMed ID: 22024150
[TBL] [Abstract][Full Text] [Related]
13. Deubiquitinating enzymes as cancer biomarkers: new therapeutic opportunities?
Poondla N; Chandrasekaran AP; Kim KS; Ramakrishna S
BMB Rep; 2019 Mar; 52(3):181-189. PubMed ID: 30760385
[TBL] [Abstract][Full Text] [Related]
14. Targeting the deubiquitinase
Zhang S; Guo Y; Zhang S; Wang Z; Zhang Y; Zuo S
Oncol Rep; 2023 Oct; 50(4):. PubMed ID: 37594087
[TBL] [Abstract][Full Text] [Related]
15. Deubiquitinase USP35 as a novel mitotic regulator via maintenance of Aurora B stability.
Park J; Song EJ
BMB Rep; 2018 Jun; 51(6):261-262. PubMed ID: 29764563
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-specific protease 2-45 (Usp2-45) binds to epithelial Na+ channel (ENaC)-ubiquitylating enzyme Nedd4-2.
Oberfeld B; Ruffieux-Daidié D; Vitagliano JJ; Pos KM; Verrey F; Staub O
Am J Physiol Renal Physiol; 2011 Jul; 301(1):F189-96. PubMed ID: 21478478
[TBL] [Abstract][Full Text] [Related]
17. Control of AIF-mediated cell death by antagonistic functions of CHIP ubiquitin E3 ligase and USP2 deubiquitinating enzyme.
Oh KH; Yang SW; Park JM; Seol JH; Iemura S; Natsume T; Murata S; Tanaka K; Jeon YJ; Chung CH
Cell Death Differ; 2011 Aug; 18(8):1326-36. PubMed ID: 21293491
[TBL] [Abstract][Full Text] [Related]
18. Gene structure, alternate splicing, tissue distribution, cellular localization, and developmental expression pattern of mouse deubiquitinating enzyme isoforms Usp2-45 and Usp2-69.
Gousseva N; Baker RT
Gene Expr; 2003; 11(3-4):163-79. PubMed ID: 14686789
[TBL] [Abstract][Full Text] [Related]
19. [Effects of ubiquitin-specific proteases 2-69 on proliferation of breast cancer cells].
Liu JY; Zou LP; Wu HJ; Zhao ZH; Zhang ZG
Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):455-460. PubMed ID: 29886591
[No Abstract] [Full Text] [Related]
20. Transient kinetic analysis of USP2-catalyzed deubiquitination reveals a conformational rearrangement in the K48-linked diubiquitin substrate.
Bozza WP; Liang Q; Gong P; Zhuang Z
Biochemistry; 2012 Dec; 51(50):10075-86. PubMed ID: 23211065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
